Skip to main content
AI/ML Innovations Inc. logo

AI/ML Innovations Inc. — Investor Relations & Filings

Ticker · AIML ISIN · CA00143Y1034 LEI · 5493004TJHMBXORVTD12 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 532 across all filing types
Latest filing 2024-03-13 Regulatory Filings
Country CA Canada
Listing CSE AIML

About AI/ML Innovations Inc.

https://aiml-innovations.com/

AI/ML Innovations Inc. is a digital healthcare technology company specializing in the application of Artificial Intelligence (AI) and Machine Learning (ML) neural networks to revolutionize non-invasive medicine and biometric intelligence. The company develops proprietary platforms that leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights, supporting proactive and personalized care. Its flagship technology, MaxYield, is a cutting-edge Signal Processing Neural Network designed to extract high-fidelity signals from noisy recordings, initially focused on enhancing the clarity and accuracy of ECG data by delivering clean, "Neuralized" waveforms and precise PQRST data walls. Through its subsidiaries, the company provides AI-powered solutions like CardioYield™ for Holter analysis, aiming to integrate seamlessly with existing clinical and wellness workflows.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing a new product launch by AI/ML Innovations Inc. and its subsidiary Health Gauge Inc. It focuses on describing the features and value proposition of 'The Pulse Guru', a wearable health sensor product. There is no indication of financial data, regulatory filings, management changes, or shareholder information. The document is promotional and informational in nature, typical of a press release. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is a general regulatory announcement or news release, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2024-03-13 English
News release - English.pdf
Regulatory Filings
2024-03-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing the commercial launch of a new product called "Follow Your Heart" by AI/ML Innovations Inc. It focuses on product features, market relevance, and company background. There is no financial data, regulatory filing, or report content such as annual or quarterly financial statements. The document is promotional and informational in nature, typical of a press release or news announcement. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the content and format, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-03-06 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a news release announcing the appointment of a new Interim Chief Product Officer and the departure of the Chief Technology Officer. It focuses on management changes and company strategy related to AI and healthcare innovation. There are no financial statements, earnings data, or detailed financial analysis present. The content is primarily about changes in senior management personnel, which fits the category of Board/Management Information (MANG). The document length is 5677 characters, which is sufficient for a detailed announcement but does not contain financial report data. Therefore, the appropriate classification is MANG with high confidence.
2024-03-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that AI/ML Innovations Inc.'s subsidiary, Health Gauge Inc., is seeking FDA 510(k) Class II certification for its blood pressure measurement technology. It highlights product development milestones, market potential, and company strategy. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a product and regulatory approval process, not a financial report, management discussion, or shareholder meeting material. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement or corporate news release, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2024-02-27 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a news release announcing the appointment of Dr. David Cramb as Chair of the Company's inaugural Science and Product Advisory Board. It focuses on management and board-related information, specifically the strategic appointment of a key advisory board member. There are no financial statements, earnings data, or regulatory filings referenced as the main content. The document is not a report, call transcript, or financial update but an announcement related to management and governance. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (6196 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2024-02-14 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.